EARLY EXPERIMENTS SHOW FAST-ACTING ANTIDOTE TARGETS CARBON MONOXIDE POISONING

Summary from the TLDR newsletter

A newly engineered protein therapy called RcoM-HBD-CCC has been shown to cling to carbon monoxide and expel the poison via the kidneys within minutes when given intravenously to mice. The protein quickly sponges up the toxin without binding to nitric oxide, a gas molecule that plays a key role in relaxing blood vessels. The protein was shown to cling to carbon monoxide in human blood in test tubes. It is unknown how the treatment will work in human bodies until it is tested, but human trials are still likely to be a few years away.